NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
$REGN Regeneron Pharma - 50d/200d ema Golden Cross on the daily chart last week after a solid earnings report in early August. Assuming bullish trend line holds, expecting continued gains over the next couple months.

Near term target - $391 (gap fill)
Medium term target - $420


Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.